TickerFacts.

Akari Therapeutics Plc (AKTX): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

90.54B
As of 2025-12-31
140.03B
As of 2026-06-30
2011-12-31: 12.10M2012-12-31: 13.37M2013-12-31: 40.23M2014-12-31: 722.35M2015-12-31: 1.18B2016-12-31: 1.18B2017-12-31: 1.53B2018-12-31: 1.58B2019-12-31: 2.25B2020-12-31: 3.85B2021-12-31: 4.76B2022-12-31: 7.44B2023-12-31: 13.23B2024-12-31: 53.19B2025-12-31: 90.54B90.54B
2011-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3190.54B+70.2%2026-03-30, Balance as of period end
2024-12-3153.19Bn/c2026-03-30, Balance as of period end
2023-12-3113.23B+77.8%2025-04-15, Balance as of period end
2022-12-317.44Bn/c2024-03-29, Balance as of period end
2021-12-314.76Bn/c2023-05-01, Balance as of period end
2020-12-313.85B+71.3%2022-05-16, Balance as of period end
2019-12-312.25B+42.1%2021-04-21, Balance as of period end
2018-12-311.58B+3.6%2020-03-31, Balance as of period end
2017-12-311.53B+29.5%2019-04-23, Balance as of period end
2016-12-311.18B0.0%2018-07-18, Balance as of period end
2015-12-311.18B+63.0%2017-03-31, Balance as of period end
2014-12-31722.35Mn/m2016-03-23, Balance as of period end
2013-12-3140.23Mn/c2015-02-11, Balance as of period end
2012-12-3113.37M+10.5%2014-03-24, Balance as of period end
2011-12-3112.10Mn/a2013-04-19, Balance as of period end